[noon announcement] Financial Associated Press, June 15, a number of companies issued lunch announcements, as follows: ① Enhua Pharmaceutical Co., Ltd.: recently, the company received a "Drug Supplementary Application approval notice" for Penehyclidine Hydrochloride injection approved and issued by the State Drug Administration, approving the drug to pass the consistency evaluation of generic drug quality and efficacy. Penehyclidine hydrochloride injection is a selective anticholinergic drug. ② Xinplatinum shares: Li Jie, vice chairman of the company, Chen Weirong, director and senior manager of the company, and Zhang Peihua, chairman of the board of supervisors, decided to terminate the share reduction plan ahead of schedule. From February 21, 2023 to the date of this announcement, none of the above-mentioned persons have reduced their shares in the company in any way.